APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rx Irritable Bowel Syndrome (IBS) Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Rx Irritable Bowel Syndrome (IBS) Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025180 pages

Choose your research edition.

Industry ResearchRx Irritable Bowel Syndrome (IBS) Drugs Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Rx Irritable Bowel Syndrome (IBS) Drugs Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Rx Irritable Bowel Syndrome (IBS) Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rx Irritable Bowel Syndrome (IBS) Drugs Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Rx Irritable Bowel Syndrome (IBS) Drugs Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Rx Irritable Bowel Syndrome (IBS) Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Rx Irritable Bowel Syndrome (IBS) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Rx Irritable Bowel Syndrome (IBS) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rx Irritable Bowel Syndrome (IBS) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Rx Irritable Bowel Syndrome (IBS) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Rx Irritable Bowel Syndrome (IBS) Drugs include Allergan, Bausch Health, Ironwood Pharmaceuticals, Sebela Pharmaceuticals and Takeda, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Rx Irritable Bowel Syndrome (IBS) Drugs market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Rx Irritable Bowel Syndrome (IBS) Drugs and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Rx Irritable Bowel Syndrome (IBS) Drugs revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Rx Irritable Bowel Syndrome (IBS) Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Rx Irritable Bowel Syndrome (IBS) Drugs Segment by Company

Allergan

Bausch Health

Ironwood Pharmaceuticals

Sebela Pharmaceuticals

Takeda

Rx Irritable Bowel Syndrome (IBS) Drugs Segment by Type

IBS-D Drugs

IBS-C Drugs

Others

Rx Irritable Bowel Syndrome (IBS) Drugs Segment by Application

Women

Men

Rx Irritable Bowel Syndrome (IBS) Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rx Irritable Bowel Syndrome (IBS) Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rx Irritable Bowel Syndrome (IBS) Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rx Irritable Bowel Syndrome (IBS) Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Rx Irritable Bowel Syndrome (IBS) Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Rx Irritable Bowel Syndrome (IBS) Drugs industry.

Chapter 3: Detailed analysis of Rx Irritable Bowel Syndrome (IBS) Drugs companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rx Irritable Bowel Syndrome (IBS) Drugsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of IBS-D Drugs Table 3. Key Players of IBS-C Drugs Table 4. Key Players of Others Table 4. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Women Table 6. Key Players of Men Table 7. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Region (2021-2026) Table 10. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Region (2027-2032) Table 12. Rx Irritable Bowel Syndrome (IBS) Drugs Industry Trends Table 13. Rx Irritable Bowel Syndrome (IBS) Drugs Industry Drivers Table 14. Rx Irritable Bowel Syndrome (IBS) Drugs Industry Opportunities and Challenges Table 15. Rx Irritable Bowel Syndrome (IBS) Drugs Industry Restraints Table 16. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Company (2021-2026) Table 18. Global Rx Irritable Bowel Syndrome (IBS) Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Rx Irritable Bowel Syndrome (IBS) Drugs Key Company Head Office and Area Served Table 20. Global Rx Irritable Bowel Syndrome (IBS) Drugs Company, Product Type & Application Table 21. Global Rx Irritable Bowel Syndrome (IBS) Drugs Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Rx Irritable Bowel Syndrome (IBS) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Type (2021-2026) Table 28. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Type (2027-2032) Table 29. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Application (2021-2026) Table 33. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Application (2027-2032) Table 34. Allergan Company Information Table 35. Allergan Business Overview Table 36. Allergan Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Allergan Rx Irritable Bowel Syndrome (IBS) Drugs Product Portfolio Table 38. Allergan Recent Development Table 39. Bausch Health Company Information Table 40. Bausch Health Business Overview Table 41. Bausch Health Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Bausch Health Rx Irritable Bowel Syndrome (IBS) Drugs Product Portfolio Table 43. Bausch Health Recent Development Table 44. Ironwood Pharmaceuticals Company Information Table 45. Ironwood Pharmaceuticals Business Overview Table 46. Ironwood Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Ironwood Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Product Portfolio Table 48. Ironwood Pharmaceuticals Recent Development Table 49. Sebela Pharmaceuticals Company Information Table 50. Sebela Pharmaceuticals Business Overview Table 51. Sebela Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Sebela Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Product Portfolio Table 53. Sebela Pharmaceuticals Recent Development Table 54. Takeda Company Information Table 55. Takeda Business Overview Table 56. Takeda Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Takeda Rx Irritable Bowel Syndrome (IBS) Drugs Product Portfolio Table 58. Takeda Recent Development Table 59. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2021-2026) & (US$ Million) Table 60. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2027-2032) & (US$ Million) Table 61. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2021-2026) & (US$ Million) Table 62. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2027-2032) & (US$ Million) Table 63. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 64. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2021-2026) Table 65. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2027-2032) Table 66. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2021-2026) & (US$ Million) Table 67. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2027-2032) & (US$ Million) Table 68. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2021-2026) & (US$ Million) Table 69. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2027-2032) & (US$ Million) Table 70. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 71. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2021-2026) Table 72. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2027-2032) Table 73. China Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2021-2026) & (US$ Million) Table 74. China Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2027-2032) & (US$ Million) Table 75. China Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2021-2026) & (US$ Million) Table 76. China Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2027-2032) & (US$ Million) Table 77. Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2021-2026) & (US$ Million) Table 78. Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2027-2032) & (US$ Million) Table 79. Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2021-2026) & (US$ Million) Table 80. Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2027-2032) & (US$ Million) Table 81. Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 82. Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2021-2026) Table 83. Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2027-2032) Table 84. South America, Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2021-2026) & (US$ Million) Table 85. South America, Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2027-2032) & (US$ Million) Table 86. South America, Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2021-2026) & (US$ Million) Table 87. South America, Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2027-2032) & (US$ Million) Table 88. South America, Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. South America, Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2021-2026) Table 90. South America, Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2027-2032) Table 91. Research Programs/Design for This Report Table 92. Authors List of This Report Table 93. Secondary Sources Table 94. Primary Sources List of Figures Figure 1. Rx Irritable Bowel Syndrome (IBS) Drugs Product Image Figure 2. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type: 2025 VS 2032 Figure 4. IBS-D Drugs Image Figure 5. IBS-C Drugs Image Figure 6. Others Image Figure 7. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application: 2025 VS 2032 Figure 9. Women Image Figure 10. Men Image Figure 11. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2021-2032) & (US$ Million) Figure 13. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Rx Irritable Bowel Syndrome (IBS) Drugs Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Type (2021-2032) Figure 20. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Application (2021-2032) Figure 22. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2021-2032) & (US$ Million) Figure 23. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2021-2032) Figure 24. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2021-2032) Figure 25. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Country (2021-2032) Figure 26. United States Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2021-2032) & (US$ Million) Figure 27. Canada Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2021-2032) & (US$ Million) Figure 29. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2021-2032) & (US$ Million) Figure 30. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2021-2032) Figure 31. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2021-2032) Figure 32. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Country (2021-2032) Figure 33. Germany Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2021-2032) & (US$ Million) Figure 34. France Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2021-2032) & (US$ Million) Figure 36. Italy Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2021-2032) & (US$ Million) Figure 37. Russia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2021-2032) & (US$ Million) Figure 39. China Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2021-2032) & (US$ Million) Figure 40. China Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2021-2032) Figure 41. China Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2021-2032) Figure 42. Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2021-2032) & (US$ Million) Figure 43. Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2021-2032) Figure 44. Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2021-2032) Figure 45. Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Country (2021-2032) Figure 46. Japan Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2021-2032) & (US$ Million) Figure 50. India Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2021-2032) & (US$ Million) Figure 51. Australia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Country (2021-2032) Figure 56. Brazil Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2021-2032) & (US$ Million) Figure 61. UAE Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2021-2032) & (US$ Million) Figure 63. Chile Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • IBS-D Drugs
  • IBS-C Drugs
  • Others
Applications
  • Women
  • Men
Companies covered
  • Allergan
  • Bausch Health
  • Ironwood Pharmaceuticals
  • Sebela Pharmaceuticals
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 IBS-D Drugs
  5. 1.2.3 IBS-C Drugs
  6. 1.2.4 Others
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Women
  10. 1.3.3 Men
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Rx Irritable Bowel Syndrome (IBS) Drugs Growth Trends by Region
  13. 1.5.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (2021-2026)
  15. 1.5.3 Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Dynamics
  1. 2.1 Rx Irritable Bowel Syndrome (IBS) Drugs Industry Trends
  2. 2.2 Rx Irritable Bowel Syndrome (IBS) Drugs Industry Drivers
  3. 2.3 Rx Irritable Bowel Syndrome (IBS) Drugs Industry Opportunities and Challenges
  4. 2.4 Rx Irritable Bowel Syndrome (IBS) Drugs Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Company (2021-2026)
  2. 3.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Rx Irritable Bowel Syndrome (IBS) Drugs Key Company Head office and Area Served
  4. 3.4 Global Rx Irritable Bowel Syndrome (IBS) Drugs Company, Product Type & Application
  5. 3.5 Global Rx Irritable Bowel Syndrome (IBS) Drugs Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Rx Irritable Bowel Syndrome (IBS) Drugs Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Rx Irritable Bowel Syndrome (IBS) Drugs Tier 1, Tier 2, and Tier 3
4 Rx Irritable Bowel Syndrome (IBS) Drugs Market by Type
  1. 4.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2021-2032)
  3. 4.3 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Share by Type (2021-2032)
5 Rx Irritable Bowel Syndrome (IBS) Drugs Market by Application
  1. 5.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2021-2032)
  3. 5.3 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Allergan
  2. 6.1.1 Allergan Company Information
  3. 6.1.2 Allergan Business Overview
  4. 6.1.3 Allergan Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Allergan Rx Irritable Bowel Syndrome (IBS) Drugs Product Portfolio
  6. 6.1.5 Allergan Recent Developments
  7. 6.2 Bausch Health
  8. 6.2.1 Bausch Health Company Information
  9. 6.2.2 Bausch Health Business Overview
  10. 6.2.3 Bausch Health Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Bausch Health Rx Irritable Bowel Syndrome (IBS) Drugs Product Portfolio
  12. 6.2.5 Bausch Health Recent Developments
  13. 6.3 Ironwood Pharmaceuticals
  14. 6.3.1 Ironwood Pharmaceuticals Company Information
  15. 6.3.2 Ironwood Pharmaceuticals Business Overview
  16. 6.3.3 Ironwood Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Ironwood Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Product Portfolio
  18. 6.3.5 Ironwood Pharmaceuticals Recent Developments
  19. 6.4 Sebela Pharmaceuticals
  20. 6.4.1 Sebela Pharmaceuticals Company Information
  21. 6.4.2 Sebela Pharmaceuticals Business Overview
  22. 6.4.3 Sebela Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Sebela Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Product Portfolio
  24. 6.4.5 Sebela Pharmaceuticals Recent Developments
  25. 6.5 Takeda
  26. 6.5.1 Takeda Company Information
  27. 6.5.2 Takeda Business Overview
  28. 6.5.3 Takeda Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Takeda Rx Irritable Bowel Syndrome (IBS) Drugs Product Portfolio
  30. 6.5.5 Takeda Recent Developments
7 North America
  1. 7.1 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2021-2032)
  2. 7.2 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type
  3. 7.2.1 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2021-2026)
  4. 7.2.2 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2027-2032)
  5. 7.2.3 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2021-2032)
  6. 7.3 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application
  7. 7.3.1 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2021-2026)
  8. 7.3.2 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2027-2032)
  9. 7.3.3 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2021-2032)
  10. 7.4 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country
  11. 7.4.1 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2021-2026)
  13. 7.4.3 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2027-2032)
  14. 7.4.4 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2021-2032)
  2. 8.2 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type
  3. 8.2.1 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2021-2026)
  4. 8.2.2 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2027-2032)
  5. 8.2.3 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2021-2032)
  6. 8.3 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application
  7. 8.3.1 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2021-2026)
  8. 8.3.2 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2027-2032)
  9. 8.3.3 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2021-2032)
  10. 8.4 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country
  11. 8.4.1 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2021-2026)
  13. 8.4.3 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2027-2032)
  14. 8.4.4 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2021-2032)
  2. 9.2 China Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type
  3. 9.2.1 China Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2021-2026)
  4. 9.2.2 China Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2027-2032)
  5. 9.2.3 China Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2021-2032)
  6. 9.3 China Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application
  7. 9.3.1 China Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2021-2026)
  8. 9.3.2 China Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2027-2032)
  9. 9.3.3 China Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2021-2032)
  2. 10.2 Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type
  3. 10.2.1 Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2021-2026)
  4. 10.2.2 Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2027-2032)
  5. 10.2.3 Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2021-2032)
  6. 10.3 Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application
  7. 10.3.1 Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2021-2026)
  8. 10.3.2 Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2027-2032)
  9. 10.3.3 Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2021-2032)
  10. 10.4 Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country
  11. 10.4.1 Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2021-2026)
  13. 10.4.3 Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2027-2032)
  14. 10.4.4 Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst